Norway· NO-ID_3C2DC9FF-E0EF-4F8A-9BC1-0C4D6294E0C7
NexoBrid
A bromelains product containing concentrate of proteolytic enzymes enriched in bromelain, registered in Norway by MediWound Germany GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Bromelains is registered in 11 of 19 countries.
Countries holding a registration under ATC D03BA03 (bromelains), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Bromelains · ATC D03BA03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Concentrate Of Proteolytic Enzymes Enriched In Bromelain
- Manufacturer
- MediWound Germany GmbH
- Country
- Norway (NO)
- ATC code
- D03BA03
- ATC class
- Bromelains
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_3C2DC9FF-E0EF-4F8A-9BC1-0C4D6294E0C7
- no_varenummer1721921NOK 15783.3
- gtin7046260785861
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bromelains in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNexobrid 5 gMediwound Germany
- CzechiaNEXOBRIDMediWound Germany GmbH, Rüsselsheim
- SpainNEXOBRID 5 g polvo y gel para gelMediwound Germany Gmbh
- SwedenNexoBrid 5 g Pulver och gel till gelMediWound Germany GmbH
- GermanyBromelain-PosUrsapharm Arzneimittel Gmbh
- United KingdomBackOsamine tabletsOptima Consumer Health Ltd
- PolandNexoBridMediWound Germany GmbH
- SwitzerlandNexoBrid, poudre et gel pour gelTriskel INTEGRATED SERVICES SA
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Bromelain-Pos, Bromelaintabletten Hysan
- Iceland · Nexobrid
- Liechtenstein · Nexobrid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccf914bf-0469-410d-9725-7daff577f0af GET /v1/drugs/ccf914bf-0469-410d-9725-7daff577f0af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og gel til gel",
"source": "fest",
"status": "A",
"atc_name": "Bromelener",
"merkevare_id": "ID_3C2DC9FF-E0EF-4F8A-9BC1-0C4D6294E0C7",
"name_form_strength": "NexoBrid pulv og gel til gel 5 g",
"prescription_group": "C"
}See everything about bromelains.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.